Related Experiment Videos

Clinical pharmacology of cefadroxil in infants and children

Insights

Cefadroxil suspension shows effective pharmacokinetics in children, with consistent serum levels and good urine excretion. It proved as effective as penicillin G for impetigo, suggesting its utility for pediatric infections.

Area of Science:

  • Pediatric Pharmacology
  • Infectious Diseases

Background:

  • Cefadroxil is a cephalosporin antibiotic used for bacterial infections.
  • Understanding its pharmacokinetic profile in children is crucial for appropriate dosing and efficacy.

Purpose of the Study:

  • To evaluate the pharmacokinetics of cefadroxil suspension in pediatric patients.
  • To assess the clinical efficacy of cefadroxil compared to penicillin G in children with impetigo.

Main Methods:

  • Pharmacokinetic study involving 30 children (13 months to 12 years) receiving cefadroxil suspension.
  • Randomized controlled trial comparing cefadroxil to penicillin G in 50 children with impetigo.

Main Results:

  • Peak serum concentrations were achieved with 10- and 15-mg/kg doses, unaffected by feeding status.
  • Serum half-life ranged from 1.3 to 1.5 hours; cefadroxil was detected in saliva and urine.
  • Cefadroxil demonstrated comparable efficacy to penicillin G in treating and preventing impetigo lesions.

Conclusions:

  • Cefadroxil suspension exhibits predictable pharmacokinetics in children.
  • Cefadroxil is a viable therapeutic option for impetigo and potentially other mucocutaneous and urinary tract infections in pediatric populations.

Related Concept Videos